Page last updated: 2024-09-02

ecteinascidin 743 and Cancer, Second Primary

ecteinascidin 743 has been researched along with Cancer, Second Primary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Douer, D; Liu, SV; Tahbaz, A; Zneimer, S1

Other Studies

1 other study(ies) available for ecteinascidin 743 and Cancer, Second Primary

ArticleYear
Therapy-related acute myeloid leukemia following treatment with trabectedin for Ewing's sarcoma.
    Acta haematologica, 2011, Volume: 126, Issue:2

    Topics: Adult; Antineoplastic Agents, Alkylating; Bone Neoplasms; Dioxoles; Etoposide; Fatal Outcome; Female; Gene Deletion; Gene Rearrangement; Humans; Leukemia, Myeloid, Acute; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Sarcoma, Ewing; Tetrahydroisoquinolines; Topoisomerase Inhibitors; Trabectedin; Young Adult

2011